TEM Latest Headlines

Tempus AI's FDA-Cleared ECG Model Hits Milestone with Multi-Site Validation for Atrial Fibrillation Risk

Market Chameleon (Fri, 12-Jun 11:22 AM)

Tempus to Share AI-Powered Precision Medicine Advancements at Goldman Sachs Global Healthcare Conference

Market Chameleon (Mon, 8-Jun 7:32 AM)

Tempus Launches Open-Source Digital Pathology Consortium With Yale and MSK, Signaling Push Toward Accessible AI-Enabled Medical Data

Market Chameleon (Thu, 4-Jun 11:44 AM)

FDA Approval for Tempus’ Tumor-Only xT CDx Set to Reshape Genomic Profiling in Oncology

Market Chameleon (Fri, 29-May 8:32 AM)

Tempus Sees Record 37 Research Abstracts Accepted for 2026 ASCO Meeting—AI Insights Drive Oncology Progress

Market Chameleon (Tue, 26-May 8:40 AM)

Tempus Expands Clinical Offerings with ArteraAI Prostate Test Integration, Delivering First Digital Pathology Algorithm for Metastatic Prostate Cancer

Market Chameleon (Thu, 21-May 9:00 AM)

Tempus Raises $400 Million in Upsized Convertible Notes Offering with 40% Conversion Premium

Market Chameleon (Fri, 8-May 7:15 AM)

Tempus Collaboration Expands Access to Blood-Based Alzheimer’s Testing for Neurologists

Market Chameleon (Wed, 6-May 8:18 AM)

Tempus Earns Spot on TIME’s 10 Most Influential Health and Life Science Companies—Industry Leadership Brings Focus on AI-Driven Precision Medicine

Market Chameleon (Tue, 28-Apr 8:49 AM)

TEM's Collaboration with USC Targets 1.5 Million Patient Visits and Sets AI-Driven Precision Care in Motion

Market Chameleon (Thu, 23-Apr 8:50 AM)